{"id":1000214,"date":"2026-09-03T08:10:33","date_gmt":"2026-09-03T12:10:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/"},"modified":"2026-09-03T08:10:33","modified_gmt":"2026-09-03T12:10:33","slug":"invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/","title":{"rendered":"Invivyd\u00a0Reports\u00a0Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\u00a0"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">NEW HAVEN, Conn., Sept.  03, 2026  (GLOBE NEWSWIRE) &#8212; Invivyd, Inc. (Nasdaq: IVVD) today announced that on September 1, 2026, Invivyd granted six newly hired non-executive employees options to purchase an aggregate of 255,000 shares of its common stock, each as a material inducement for each employee\u2019s entry into employment with Invivyd. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4) and pursuant to the Invivyd, Inc. 2026 Inducement Plan.\u00a0<\/p>\n<p>The options have a per share exercise price of $0.8799, representing the closing price of Invivyd\u2019s common stock on the grant date. Each option vests over four years, with 25% of the shares subject to such option vesting on the first anniversary of the employee\u2019s start date and the remaining shares vesting in equal monthly installments thereafter, in each case, subject to the employee\u2019s continuous service with Invivyd. The options have a 10-year term and are subject to the terms of the Invivyd, Inc. 2026 Inducement Plan.\u00a0<\/p>\n<p>\n        <strong>About Invivyd<\/strong>\u202f\u202f\u00a0<\/p>\n<p>Invivyd, Inc. (Nasdaq: IVVD) is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, beginning with SARS-CoV-2. Invivyd deploys a proprietary integrated technology platform unique in the industry designed to assess, monitor, develop, and adapt to create best in class antibodies. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody (mAb) in its pipeline of innovative antibody candidates. Visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=KYSMRjOmwR-S-VvWg8g0ULe9T-YUn2iv8M81h1UMaA5qn1DMW2EsF-pSo9MRjRFF-IZwjZ8utTWbEEYzgcMcaUcNp1IqNXDH2lMT1-tZ4z4=\" rel=\"nofollow\" target=\"_blank\">https:\/\/invivyd.com\/<\/a> to learn more.\u202f\u00a0<\/p>\n<p>This press release\u00a0contains\u00a0hyperlinks to information that is not\u00a0deemed\u00a0to be incorporated by reference in this press release.\u00a0<\/p>\n<p>\n        <strong>Contacts:<\/strong>\u00a0<\/p>\n<p>\n        <strong>Media Relations<\/strong>\u00a0<br \/>(781) 208-0160\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3GNWx_tjHAbQNAQeXdEQROBiIm-LAKAyuUJvPR1pTbHMWwOxv2V84W_mwIKEbUDP_yFoxdzrm_JjZpo2fehd8rfr3jkY4Yg3dGOGD5cnwn4=\" rel=\"nofollow\" target=\"_blank\">media@invivyd.com<\/a>\u00a0<\/p>\n<p>\n        <strong>Investor Relations<\/strong>\u00a0<br \/>(781) 208-1747\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3LO4JcZrmuIDMrrmwKyPeL71CEuDDDXjm0E-Wq_1q5QS5ntgiFmpZYKwhtOqUz1usaKnF7QJ8040W39U-N4lXAFtcih8qU8FW09x2xCtIwo=\" rel=\"nofollow\" target=\"_blank\">investors@invivyd.com<\/a>\u00a0<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDU0NCM3ODE1NzM1IzIyMDk3NjE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZjYxOGRhMjItNDdkYS00OTg5LWE2NzUtNTAxNzlhMmFkMmVmLTEyMjEzMTQtMjAyNi0wOS0wMy1lbg==\/tiny\/Invivyd.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) &#8212; Invivyd, Inc. (Nasdaq: IVVD) today announced that on September 1, 2026, Invivyd granted six newly hired non-executive employees options to purchase an aggregate of 255,000 shares of its common stock, each as a material inducement for each employee\u2019s entry into employment with Invivyd. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4) and pursuant to the Invivyd, Inc. 2026 Inducement Plan.\u00a0 The options have a per share exercise price of $0.8799, representing the closing price of Invivyd\u2019s common stock on the grant date. Each option vests over four years, with 25% of the shares subject to such option vesting on the first anniversary of the employee\u2019s start date and &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Invivyd\u00a0Reports\u00a0Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\u00a0&#8220;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1000214","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Invivyd\u00a0Reports\u00a0Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\u00a0 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Invivyd\u00a0Reports\u00a0Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\u00a0 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) &#8212; Invivyd, Inc. (Nasdaq: IVVD) today announced that on September 1, 2026, Invivyd granted six newly hired non-executive employees options to purchase an aggregate of 255,000 shares of its common stock, each as a material inducement for each employee\u2019s entry into employment with Invivyd. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4) and pursuant to the Invivyd, Inc. 2026 Inducement Plan.\u00a0 The options have a per share exercise price of $0.8799, representing the closing price of Invivyd\u2019s common stock on the grant date. Each option vests over four years, with 25% of the shares subject to such option vesting on the first anniversary of the employee\u2019s start date and &hellip; Continue reading &quot;Invivyd\u00a0Reports\u00a0Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\u00a0&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-09-03T12:10:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDU0NCM3ODE1NzM1IzIyMDk3NjE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Invivyd\u00a0Reports\u00a0Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\u00a0\",\"datePublished\":\"2026-09-03T12:10:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\\\/\"},\"wordCount\":274,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMDU0NCM3ODE1NzM1IzIyMDk3NjE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\\\/\",\"name\":\"Invivyd\u00a0Reports\u00a0Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\u00a0 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMDU0NCM3ODE1NzM1IzIyMDk3NjE=\",\"datePublished\":\"2026-09-03T12:10:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMDU0NCM3ODE1NzM1IzIyMDk3NjE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTgyMDU0NCM3ODE1NzM1IzIyMDk3NjE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Invivyd\u00a0Reports\u00a0Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\u00a0\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Invivyd\u00a0Reports\u00a0Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\u00a0 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/","og_locale":"en_US","og_type":"article","og_title":"Invivyd\u00a0Reports\u00a0Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\u00a0 - Market Newsdesk","og_description":"NEW HAVEN, Conn., Sept. 03, 2026 (GLOBE NEWSWIRE) &#8212; Invivyd, Inc. (Nasdaq: IVVD) today announced that on September 1, 2026, Invivyd granted six newly hired non-executive employees options to purchase an aggregate of 255,000 shares of its common stock, each as a material inducement for each employee\u2019s entry into employment with Invivyd. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4) and pursuant to the Invivyd, Inc. 2026 Inducement Plan.\u00a0 The options have a per share exercise price of $0.8799, representing the closing price of Invivyd\u2019s common stock on the grant date. Each option vests over four years, with 25% of the shares subject to such option vesting on the first anniversary of the employee\u2019s start date and &hellip; Continue reading \"Invivyd\u00a0Reports\u00a0Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\u00a0\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/","og_site_name":"Market Newsdesk","article_published_time":"2026-09-03T12:10:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDU0NCM3ODE1NzM1IzIyMDk3NjE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Invivyd\u00a0Reports\u00a0Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\u00a0","datePublished":"2026-09-03T12:10:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/"},"wordCount":274,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDU0NCM3ODE1NzM1IzIyMDk3NjE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/","name":"Invivyd\u00a0Reports\u00a0Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\u00a0 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDU0NCM3ODE1NzM1IzIyMDk3NjE=","datePublished":"2026-09-03T12:10:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDU0NCM3ODE1NzM1IzIyMDk3NjE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTgyMDU0NCM3ODE1NzM1IzIyMDk3NjE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/invivyd-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-6\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Invivyd\u00a0Reports\u00a0Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)\u00a0"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1000214","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1000214"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1000214\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1000214"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1000214"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1000214"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}